261 related articles for article (PubMed ID: 12967336)
1. The effects of serine proteinase inhibitors on bone resorption in vitro.
Tumber A; Papaioannou S; Breckon J; Meikle MC; Reynolds JJ; Hill PA
J Endocrinol; 2003 Sep; 178(3):437-47. PubMed ID: 12967336
[TBL] [Abstract][Full Text] [Related]
2. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor.
Leloup G; Lemoine P; Carmeliet P; Vaes G
J Bone Miner Res; 1996 Aug; 11(8):1146-57. PubMed ID: 8854251
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
4. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators are involved in the degradation of bone by osteoclasts.
Everts V; Daci E; Tigchelaar-Gutter W; Hoeben KA; Torrekens S; Carmeliet G; Beertsen W
Bone; 2008 Nov; 43(5):915-20. PubMed ID: 18691680
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
Schnaper HW; Barnathan ES; Mazar A; Maheshwari S; Ellis S; Cortez SL; Baricos WH; Kleinman HK
J Cell Physiol; 1995 Oct; 165(1):107-18. PubMed ID: 7559792
[TBL] [Abstract][Full Text] [Related]
7. The cellular actions of interleukin-11 on bone resorption in vitro.
Hill PA; Tumber A; Papaioannou S; Meikle MC
Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
[TBL] [Abstract][Full Text] [Related]
8. Relationship of the plasminogen activator/plasmin cascade to osteoclast invasion and mineral resorption in explanted fetal metatarsal bones.
Leloup G; Delaisse JM; Vaes G
J Bone Miner Res; 1994 Jun; 9(6):891-902. PubMed ID: 8079664
[TBL] [Abstract][Full Text] [Related]
9. Human breast-cancer cells stimulate the fusion, migration and resorptive activity of osteoclasts in bone explants.
Tumber A; Morgan HM; Meikle MC; Hill PA
Int J Cancer; 2001 Mar; 91(5):665-72. PubMed ID: 11267975
[TBL] [Abstract][Full Text] [Related]
10. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation.
Hägglund AC; Ny A; Liu K; Ny T
Endocrinology; 1996 Dec; 137(12):5671-7. PubMed ID: 8940398
[TBL] [Abstract][Full Text] [Related]
11. Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.
Netzel-Arnett S; Mitola DJ; Yamada SS; Chrysovergis K; Holmbeck K; Birkedal-Hansen H; Bugge TH
J Biol Chem; 2002 Nov; 277(47):45154-61. PubMed ID: 12192005
[TBL] [Abstract][Full Text] [Related]
12. The effect of tissue type plasminogen activator (tPA) on osteoclastic resorption in embryonic mouse long bone explants: a possible role for the growth factor domain of tPA.
Hoekman K; Löwik CW; van de Ruit M; Bijvoet OL; Verheijen JH; Papapoulos SE
Bone Miner; 1992 Apr; 17(1):1-13. PubMed ID: 1533805
[TBL] [Abstract][Full Text] [Related]
13. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
14. The role of the plasminogen system in bone resorption in vitro.
Daci E; Udagawa N; Martin TJ; Bouillon R; Carmeliet G
J Bone Miner Res; 1999 Jun; 14(6):946-52. PubMed ID: 10352103
[TBL] [Abstract][Full Text] [Related]
15. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
Perez-Amodio S; Beertsen W; Everts V
J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
[TBL] [Abstract][Full Text] [Related]
16. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts.
Hill PA; Murphy G; Docherty AJ; Hembry RM; Millican TA; Reynolds JJ; Meikle MC
J Cell Sci; 1994 Nov; 107 ( Pt 11)():3055-64. PubMed ID: 7699005
[TBL] [Abstract][Full Text] [Related]
17. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
Wells JM; Strickland S
J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
[TBL] [Abstract][Full Text] [Related]
18. Expression of plasminogen activator and inhibitor, urokinase receptor and inhibin subunits in rhesus monkey testes.
Zhang T; Zhou HM; Liu YX
Mol Hum Reprod; 1997 Mar; 3(3):223-31. PubMed ID: 9237248
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase.
Hill PA; Docherty AJ; Bottomley KM; O'Connell JP; Morphy JR; Reynolds JJ; Meikle MC
Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):167-75. PubMed ID: 7755562
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]